Find a Doctor

Rachel Weinerman, MD

Rachel Weinerman, MD

Ratings

(4.8)

30 Ratings 0 Reviews

Specialty

Reproductive Endocrinology

Accepting New Patients

Schedule an Appointment

(216)285-5028

Request a Call Back

Biography

Expertise

  • Amenorrhea
  • Intrauterine Insemination
  • Recurrent Pregnancy Loss

Awards

2015   Luigi Mastroianni Research Award, Philadelphia Area Reproductive Endocrine Society
2015   Society for Reproductive Endocrinology Prize Paper Award, American Society for Reproductive Medicine Annual Meeting, Baltimore, MD
2014   Research grant from the Foundation for the Assessment and Enhancement of Embryonic Competence
2014   Society of Reproductive Biologists Award for oral presentation at the American Society for Reproductive Medicine Annual Meeting, Honolulu, HI
2013   National Research Service Institutional Training Award (T32), University of Pennsylvania

Office Locations

UH Fertility Center

1000 Auburn Dr
Beachwood OH, 44122

Get Directions >

2055 Crocker Rd
Westlake OH, 44145

Get Directions >

Patient Satisfaction Reviews

4.8 out of 5

30 Ratings

Board Certifications

  • Reproductive Endocrinology/Infertility - American Board of Obstetrics and Gynecology
  • Obstetrics and Gynecology - American Board of Obstetrics and Gynecology

Education

Fellowship | Reproductive Endocrinology
Reproductive Endocrinology - University Of Pennsylvania School Of Medicine (2012 - 2015)

Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - New York University School Of Medicine And Langone Medical Center (2008 - 2012)

Medical Education
Harvard Medical School (2008)

Undergraduate
Harvard University (2003)

Research Interests

In-vitro fertilization perinatal outcomes, Embryo selection, Embryo vitrification

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Rachel Weinerman did not disclose any Outside Relationships with Industry.